Oncology Institute(The) - Warrants (15/11/2026) Receivables

The latest receivables for TOIIW is $67M as of June 2026. That compares with $56M in the prior-year period — up 19.3% year over year. Investors often review this figure alongside Oncology Institute(The) - Warrants (15/11/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, TOIIW's receivables moved from $56M to $67M — a 19.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Oncology Institute(The) - Warrants (15/11/2026)'s operating scale or balance-sheet position.

A receivables figure of $67M for TOIIW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TOIIW's receivables ($67M), review year-over-year change from $56M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.